Comparison of the Efficacies and Safety of Combined Therapy between Telbivudine Plus Adefovir and Lamivudine Plus Adefovir in Patients with Hepatitis B Virus Infection in Real-World Practice

BACKGROUND AND AIM: Chronic hepatitis B infection remains a significant health issue worldwide. This study evaluated the efficacy and safety of combined therapy using lamivudine plus adefovir (LAM+ADV) versus telbivudine plus adefovir (LdT+ADV) and the corresponding renal function change and safety....

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Ming-Tsung, Yen, Yi-Hao, Tsai, Ming-Chao, Tseng, Po-Lin, Chang, Kuo-Chin, Wu, Cheng-Kun, Hu, Tsung-Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5091898/
https://www.ncbi.nlm.nih.gov/pubmed/27806120
http://dx.doi.org/10.1371/journal.pone.0165416

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5091898/
https://www.ncbi.nlm.nih.gov/pubmed/27806120
http://dx.doi.org/10.1371/journal.pone.0165416

Ejemplares similares